The Association Between Incident Lung Cancer and Hormone Replacement Therapy in a Large Cohort

Early Detection Research Award
Funded by LUNGevity Foundation and The CHEST Foundation
Christopher G. Slatore, MD, MS
University of Washington School of Medicine
Seattle
WA

Previously conducted clinical trials have suggested an increased risk of lung cancer from hormone replacement therapy (HRT). Dr. Slatore is studying women who have both undergone HRT and smoked  to determine whether there is a relationship between HRT, tobacco use, and lung cancer.